Summary of the invention
The objective of the invention is to overcome above-mentioned the deficiencies in the prior art part, and easily manufactured, effective peptide milk (trade name: sunrise is peptide milk too) and preparation technology thereof is provided.
The object of the invention can realize by following measure:
Peptide milk, form by following raw materials according and prescription:
Plain chocolate 94-96%
White granulated sugar 0.5-3%
Bone marrow peptide 0-3%
Placenta peptide 0-0.5%
Collagen peptide 0-1%
Stabilizing agent 0-0.2%
Flavoring essence 0-0.04%
The surplus water is regulated, and the content sum of above each component percentage by weight is 100%, contains a little soda ash, and its consumption is ignored.
Preparation technology is as follows:
1, milk collection
Regain fresh milk from the pasture, through outgasing, filter, cool off, go into milk container refrigeration.
2, give processing
1) adjustment of bone marrow peptide, placenta peptide, three kinds of peptide powder of collagen peptide PH
The peptide powder is accurately measured, and PH to 7 is transferred in water dissolving, be cooled to 20 ℃ stand-by.
2) preparation of small powder
Stabilizing agent is added a little granulated sugar,, in the pasty state, cross colloid mill, remaining granulated sugar water dissolving is cooled to 20 ℃ fully with the warm milk dissolving.
3) pure milk gives processing
The pure milk of refrigeration is squeezed into compensating groove, be heated to 35-40 ℃, sterilization, cooling enter blend tank.
4) allotment of peptide milk
The stabilizing agent, peptide powder, small powder, flavoring essence and the soda ash that prepare are added in the pure milk successively, stir.
3, superhigh temperature
Peptide is suckled after filtration, is preheated to 65 ℃ of degassings, the homogenizer homogeneous, and pressure 180-200bar, homogeneous milk enters 140 ℃ of UHTSs through 90 ℃ of protein protections, is cooled to various conventional postprocessing working procedures such as 25 ℃ of cans, de-bubble again, vanning.
Three kinds of active peptide powder introductions:
1, the bone marrow peptide that extracts from the fresh ox and sheep bone meat tissue
Nourishing peaceful polypeptide is the bone marrow peptide that my company extracts from the fresh ox and sheep bone meat tissue, is had " regulating immunity " health care foods by health ministry approval production in 1997.This active peptide product is added in the milk, and the peptide milk of making has immunoregulatory effect undoubtedly.
2, from the placenta peptide of sheep placenta dish tissue extraction
Placenta has abundant nutrition and special physiological action, and the effective ingredient in the placenta has the function of beauty treatment and extensively approved.My company adopts biotechnology, nutriment in the placenta is separated purifies, and its macromolecular good protein is become active peptide through proteasome degradation, more after filtration, ultrafiltration, concentrate, drying forms the placenta peptide powder.This peptide powder is added the liquid peptide milk of making in the milk, have and promote cell metabolism, statocyte nutrition, beautifying face and moistering lotion, the effect that delays senility.
3, the collagen peptide that from animal skin, the tendons of beef, mutton or pork, extracts
Animal skin, the tendons of beef, mutton or pork have abundant collagen and elastin laminin, through autoclaving, protein in the tissue is soluble in water, utilize bio protease to be degraded into active peptide, ultrafiltration more after filtration,, concentrate, drying forms collagen peptide powder, this peptide powder is added the peptide milk of making in the milk, the synthetic good active basic substance that provides of collagen in the cell metabolism procedure in the skin and elastin laminin can be provided.Long-term drinking makes skin bright and clean flexible.
Three kinds of peptide opaque amount standards see the following form
The bone marrow peptide sample is delivered to nutrition and food hygiene teaching and research room of Beijing Medical University, and this teaching and research room has made health food immunoregulation effect survey report, now assay is presented below: test rating:
Spleen of mouse and thymus gland are heavy; Antibody forming cell's (PFC) mensuration improves slide method with Jerne; Delayed allergy (DTH) is measured with the pedal swelling method; The detection of macrophage phagocytic function adopts the carbon particle clearance method to measure statistical method: with two groups of mean checks.Animal used as test:
Kunming kind male and female mouse, age in 6-8 week, 18-22 gram, scientific experiment animal portion of Beijing Medical University provides, and the quality certification number is: the moving word 01-3049 of doctor.Experimental design:
Animal is divided control group, low dose group, middle dosage group and high dose group.The dosage of above-mentioned three experimental group is respectively 0.25g/Kg, 1.0g/Kg and 3.0g/Kg body weight.Be equivalent to 2.5,10 and 30 times of people's consumption every day respectively, the continuous irrigation stomach is 14 days altogether.Measurement result:
1, thymic weight of each dosage group mouse and control group more all have tangible increase, and mouse spleen weight and control group are not seen significant change (table 1).
2, middle and high dosage group mouse IgM-PFC number/full spleen and apparent in view increase (table 2) of control group.
3, the delayed allergy of high dose group mouse (DTH) relatively has obvious enhancing with control group, and low, middle dosage group and control group are not seen significant change (table 3).
4, each dosage group mouse carbon particle clearance rate (K) and clean up index (a) and control group and do not see significant change (table 4).
Table 1 bone marrow peptide is to mouse immune organ weight's influence (X ± S)
Group | n | Spleen phase counterweight | Thymus gland phase counterweight |
Solvent control | 12 | ?5.82±1.31 | ?3.70±0.68 |
Low dose group | 12 | ?5.81±1.56 | ?4.58±1.10* |
Middle dosage group | 12 | ?5.71±1.13 | ?4.54±1.27* |
High dose group | 12 | ?5.54±1.16 | ?4.48±1,02* |
Heavy (the mg)/body weight of phase counterweight=internal organs (g) compare with control group
*P<0.05
Table 2 bone marrow peptide is to the influence (XS) of mouse IgM-PFC/ spleen
Group | n | The full spleen of IgM-PFC/ |
Solvent control | 12 | ?91,201????2.24 |
Low dose group | 12 | ?117,490???1.41 |
Middle dosage group | 10 | ?234,423???1.40
** |
High dose group | 12 | ?213,796???1.44
** |
Compare with control group
*P<0.01
Table 3 bone marrow peptide is to the influence of mouse DTH reaction (X ± S)
Group | n | The foot sole of the foot increases thickness (mm) |
Solvent control | 12 | ?0.52±0.14 |
Low dose group | 12 | ?0.52±0.17 |
Middle dosage group | 12 | ?0.63±0.18 |
High dose group | 12 | ?0.66±0.18* |
Compare with control group
*P<0.05
Table 4 bone marrow peptide is to the influence of mouse carbon particle clearance (X ± S)
Group | ??n | ??K | ??α |
Solvent control | ??11 | ??0.0436±0.0180 | ??6.80±0.77 |
Low dose group | ??11 | ??0.0471±0.0077 | ??6.94±0.62 |
Middle dosage group | ??11 | ??0.0559±0.0202 | ??6.88±0.73 |
High dose group | ??12 | ??0.0380±0.0082 | ??6.81±0.49 |
Brief summary as a result:
Its mouse oral gave bone marrow peptide after 14 days, and testing result shows that bone marrow peptide is significantly increased mouse thymus weight, strengthened the effect of humoral immune function (IgM-PFC) and cellular immune function (DTH), and not seeing significantly influences macrophage phagocytic function.
" the health food function assessment is estimated and the method for inspection " according to the promulgation in 1996 of supervision department of the Ministry of Public Health carries out drosophila survival is tested in the delaying senility function detection and evaluation, now placenta peptide detected and estimates.
Animal used as test and tried thing: Drosophila melanogaster (Drosophila melanogaster).Breed according to conventional method, collect the adult that sprouts wings in 10 hours, etherization is liked, distinguishes male and female.Contain international (Shanghai/Zhangjiakou) bioengineering Co., Ltd by three batch number is provided: 970418.
Reagent and instrument: dark incubator, cultivation vial, ether, benzoic acid, beautiful material powder, brown sugar, dusty yeast, agar etc.
Animal divides into groups and is tried thing to give: animal used as test is divided into normal control (NC), low dosage (LD), middle dosage (MD) and 4 groups of high dose (HD) at random, about 100 of every group of female male drosophila, placenta peptide is added in the fruit bat basal feed of fusing, fully mix well, LD, MD and HD group are raised with the fruit bat basal feed that contains 0.2,1.0 and 5.0% placenta peptide respectively, the NC group is raised with normal diet, lasts till that experiment finishes.
Experimental procedure and method: per 25 culture tubes of weighing and be placed on of animal used as test (in 3 * 13cm), are raised in 28 ± 1 ℃, the dark incubator of relative humidity about 55%.Culture medium thickness is 0.5-1.0cm in every culture tube.Changed a subculture in every 3-4 days, regularly add up fruit bat death toll and the eliminating fruit bat because of other reasons death every day for 3 times, up to whole death.After the off-test, calculate maximum life span, average life span and half death time, maximum life span is the average of 10 fruit bat adults survival fates of every group of last death, average life span is pressed calculated with weighted average method with the death toll of difference time-to-live fruit bat, and the half death time tries to achieve with the cumulative mortality and the return law of the straight line of survival fate.
The result
Placenta peptide is to the influence of fruit bat average life span:
As can be seen from Table 1, placenta peptide low, middle dosage does not have the prolongation effect to the fruit bat average life span, and the placenta peptide of high dose is to the equal significant prolongation of fruit bat average life span.
Table 1, placenta peptide are to the influence of fruit bat average life span
Group | Sex | Sample number | Average weight (μ g) | Average life span (d)
n | The P value |
Control group | Male | ????95 | ????780 | ????30.2±9.2 | |
| Female | ????97 | ????920 | ????32.7±9.0 | |
Low dose group | Male | ????82 | ????780 | ????30.8±11.6 | ????>0.05 |
| Female | ????93 | ????920 | ????32.6±12.6 | ????>0.05 |
Middle dosage group | Male | ????83 | ????780 | ????32.1±10.7 | ????>0.05 |
| Female | ????103 | ????920 | ????34.6±10.7 | ????>0.05 |
High dose group | Male | ????93 | ????780 | ????34.0±9.7 | ????<0.05 |
| Female | ????96 | ????920 | ????35.4±10.0 | ????<0.05 |
a:X±SD
2, placenta peptide is to the influence of fruit bat half death time:
From table 2 can, the placenta peptide of low dose group is to the not prolongation effect of half death time of fruit bat, the placenta peptide of middle dosage is with female male drosophila half death time significant prolongation, the high dose placenta peptide is to female equal significant prolongation of male drosophila half death time.
Table 2, placenta peptide are to the influence of fruit bat half death time
Group | Sex | Sample number | Average weight (μ g) | The half death time (d)
n | The P value |
Control group | Male | ??95 | ????780 | ????29.0±10.3 | |
| Female | ??97 | ????920 | ????31.2±9.0 | |
Low dose group | Male | ??82 | ????780 | ????29.3±10.9 | ????>0.05 |
| Female | ??93 | ????920 | ????32.0±11.3 | ????>0.05 |
Middle dosage group | Male | ??83 | ????780 | ????31.1±9.8 | ????>0.05 |
| Female | ??103 | ????920 | ????33.8±9.0 | ????<0.05 |
High dose group | Male | ??93 | ????780 | ????32.7±10.9 | ????<0.05 |
| Female | ??96 | ????920 | ????34.2±12.0 | ????<0.01 |
a:X±SD
3, placenta peptide is to the influence of fruit bat maximum life span:
As can be seen from Table 3: the placenta peptide of low dosage does not have the prolongation effect to the maximum life span of fruit bat, in and the placenta peptide of high dose the maximum life span of female fruit bat is all had significant prolongation.
Table 3 placenta peptide is to the influence of fruit bat maximum life span
Group | Sex | Sample number | Average weight (μ) | Maximum life span (d)
n | The P value |
Control group | Male | ????95 | ????780g | 44.8±2.7(n=10) | |
| Female | ????97 | ????920 | ?47.6±2.1(n=10) | |
Low dose group | Male | ????82 | ????780 | ?44.9±2.9(n=10) | ????>0.05 |
| Female | ????93 | ????920 | ?47.4±3.9(n=10) | ????>0.05 |
Middle dosage group | Male | ????83 | ????780 | ?45.8±2.0(n=10) | ????>0.05 |
| Female | ????103 | ????920 | ?49.6±2.0(n=10) | ????<0.05 |
High dose group | Male | ????93 | ????780 | ?46.5±2.0(n=10) | ????>0.05 |
| Female | ????96 | ????920 | ?52.2±2.9(n=10) | ????<0.01 |
a:X±SD
Estimate:
From the result of above three indexs as can be seen, the placenta peptide of institute's amount of reagent all has more than one dosage that the prolongation of life span of drosophila melanogaster is had positive effect, can judge that the drosophila survival result of the test of placenta peptide is positive.
" the health food function assessment is estimated and the method for inspection " according to the promulgation in 1996 of supervision department of the Ministry of Public Health utilizes D-galactolipin aging model animal to carry out the detection and the evaluation of mouse lipid peroxide content and aging relevant enzyme, placenta peptide is detected and estimates, and its result is as follows:
1, animal:
Kunming kind female mice about 6 ages in week, weight range 18-22g is available from the PLA General Hospital Experimental Animal Center.
2, reagent:
Analyze pure D-galactolipin, thiobarbituricacid (TBA), available from Shanghai reagent two factories, tetraethoxypropane (TEP) is the Difico packing, available from chemical reagent shop, Beijing, folded ammonia sodium, reduced glutathione available from Huamei Bio-Engrg Co.,, two sulphur paranitrobenzoic acids (DTNB), available from Beijing hundred safe Biochem Technology, INC., other general reagent is all available from Military Medical Science Institute medicines and appliances storehouse.
3, animal grouping and administration:
Animal is divided into normal control (NC), D-galactolipin model contrast (DC), placenta peptide low dosage (LD), middle dosage (MD) and 5 groups of high dose (HD) at random.Every group of 10 animals.Hypodermic injection physiological saline 0.2ml behind NC and the DC group difference every day neck, hypodermic injection D-galactolipin aqueous solution 0.2ml (60mg/kg body weight) behind DC, LD, MD and HD group neck every day, LD, MD and HD treated animal gavage placenta peptide content suspension every day, and dosage is respectively 20.8 (containing selenium 8.33 μ g) and 125.0 (containing selenium 25.0 μ g) prosperous pulvis/kg of mg selenium.Be equivalent to oral minimum recommended dosage 1 capsules of normal adult day, promptly 5,10 and 30 times of 250mg (containing selenium 50 μ g) 60/kg body weight, continue to live after 30 days and kill.
4, observation index and method:
MDA content in the mouse whole blood adopts the TBA fluorescence method; GSH-PX vigor in the mouse whole blood adopts the GSH-DTNB colorimetric method.
5, statistical disposition: all data are carried out variance analysis (ANOVA) with SAS software
The result
1, placenta peptide is to the influence of MDA content in the mouse whole blood:
From result shown in the table 1 as can be seen, the placenta peptide of comparing many amount of reagent with control group all can obviously reduce the lipid peroxide content of mouse.
Table 1, placenta peptide are to the influence of MDA content in the mouse whole blood
Group | Dosage (mg/kg) | Mouse number (only) | MDA (nmol/ml whole blood)
n |
Model control group | ????0 | ????12 | ????3.63±0.17 |
The normal control group | ????0 | ????11 | ????3.80±0.15
* |
Low dose group | ????20.8 | ????11 | ????3.63±0.082## |
Middle dosage group | ????41.7 | ????9 | ????3.45±0.15
*##
|
High dose group | ????125.0 | ????11 | ????3.40±0.057
**##
|
#: compare .P<0.05:##:P<0.01 with the DC group
*: compare .P<0.05 with the NC group:
*: P<0.01
A:x ± SD2, placenta peptide are to the influence of mouse whole blood G S H-PX vigor: the result shows shown in the table 2, the placenta peptide of the institute's amount of reagent mouse whole blood that all can raise
#: compare P<0.05:##:P<0.01 with the DC group
*: compare P<0.05:##:P<0.01 with the NC group
a:X±SD
2, placenta peptide is to the influence of mouse whole blood GSH-PX vigor:
The result shows shown in the table 2, the placenta peptide of the institute's amount of reagent GSH-PX vigor in the mouse whole blood that all can raise, and wherein, middle and high dosage group is compared remarkable rising with control group.
Table 2, placenta peptide are to the influence of mouse whole blood GSH-PX vigor
Group | Dosage (mg/kg) | Mouse number (only) | Vigor (U/ml whole blood)
g |
Model control group | ????0 | ????12 | ????41.2±3.27 |
The normal control group | ????0 | ????11 | ????33.1±3.74
** |
Low dose group | ????20.8 | ????11 | ????35.6±4.70
** |
Middle dosage group | ????41.7 | ????9 | ????39.2±4.29## |
High dose group | ????125.0 | ????11 | ????42.0±3.78## |
#: compare P<0.05:##:P<0.01 with the DC group
*: compare P<0.05:##:P<0.01 with the NC group
Brief summary:
This testing result shows that the placenta Toplink significantly reduces the content of MDA in the mouse whole blood, and therefore the middle and high dosage GSH-PX vigor in the mouse whole blood that can obviously raise, can judge that placenta peptide has delaying senility function.
The key problem in technology point is the pH value of peptide, be 6.0 with the final pH value of peptide powder of zymolysis technique production, and the pH value of fresh milk is generally 6.5~6.8.If directly the peptide powder being mixed with solution adds in the pure milk, will destroy the balance of the original system of fresh milk, the result is that lamination appears in liquid peptide milk; If make peptide milk powder, after molten, the dough of floating a large amount of indissolubles on the liquid level, after the placement room temperature, the cup end, form white precipitate.If peptide liquid pH value is adjusted to the pH value identical with fresh milk, this phenomenon still exists.In order to address this problem, liquid towards milk has adopted a lot of measures, finds the binding site that combines the best of peptide and milk finally, this point is exactly a pH value 7.0, peptide liquid pH value is adjusted to 7.0, add in the pure milk, neither influence the stability that taste does not influence whole mixed system.
Stabilizing agent is C-9001-compound plain chocolate stabilizing agent, comprises single hard acid glyceride, potassium stearate, carragheen, guar gum, xanthans, sodium carboxymethylcellulose, Arabic gum, polydextrose.
The present invention's milk compared to existing technology has following advantage: product of the present invention promotes cell metabolism to people's physical efficiency regulatory function, and statocyte nutrition improves body immunity, promotes the absorption of milk constituents, more can beautifying face and moistering lotion to the Ms.